These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23793103)

  • 1. Effect of mosapride on Kv4.3 potassium channels expressed in CHO cells.
    Sung KW; Hahn SJ
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Oct; 386(10):905-16. PubMed ID: 23793103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Block of cloned Kv4.3 potassium channels by dapoxetine.
    Jeong I; Kim SW; Yoon SH; Hahn SJ
    Neuropharmacology; 2012 Jun; 62(7):2261-6. PubMed ID: 22192593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of haloperidol on Kv4.3 potassium channels.
    Lee HJ; Sung KW; Hahn SJ
    Eur J Pharmacol; 2014 Oct; 740():1-8. PubMed ID: 24998874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raloxifene inhibits cloned Kv4.3 channels in an estrogen receptor-independent manner.
    Chae YJ; Kim DH; Lee HJ; Sung KW; Kwon OJ; Hahn SJ
    Pflugers Arch; 2015 Aug; 467(8):1663-76. PubMed ID: 25231973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine blocks cloned Kv4.3 potassium channels.
    Choi JS; Hahn SJ
    Brain Res; 2012 Jul; 1466():15-23. PubMed ID: 22618310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Kv4.3 potassium channels by trazodone.
    Chae YJ; Choi JS; Hahn SJ
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):711-9. PubMed ID: 23615873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of riluzole with the closed inactivated state of Kv4.3 channels.
    Ahn HS; Kim SE; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
    J Pharmacol Exp Ther; 2006 Oct; 319(1):323-31. PubMed ID: 16815868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.
    Kim SE; Ahn HS; Choi BH; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
    J Pharmacol Exp Ther; 2007 May; 321(2):753-62. PubMed ID: 17312186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone inhibits Kv4.3 potassium channels by open-channel block and acceleration of closed-state inactivation.
    Jeong I; Choi BH; Hahn SJ
    Br J Pharmacol; 2011 Jun; 163(3):510-20. PubMed ID: 21232039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Kv4.3 by genistein via a tyrosine phosphorylation-independent mechanism.
    Kim HJ; Ahn HS; Choi BH; Hahn SJ
    Am J Physiol Cell Physiol; 2011 Mar; 300(3):C567-75. PubMed ID: 21148405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Block of Kv4.3 potassium channel by trifluoperazine independent of CaMKII.
    Chae YJ; Choi BH; Choi JS; Hahn SJ
    Neurosci Lett; 2014 Aug; 578():159-64. PubMed ID: 24993295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ranolazine on cloned cardiac kv4.3 potassium channels.
    Kim HJ; Ahn HS; Choi JS; Choi BH; Hahn SJ
    J Pharmacol Exp Ther; 2011 Dec; 339(3):952-8. PubMed ID: 21940646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lobeline, a nicotinic receptor ligand, on the cloned Kv1.5.
    Jeong I; Choi BH; Hahn SJ
    Pflugers Arch; 2010 Oct; 460(5):851-62. PubMed ID: 20734202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riluzole inhibits Kv4.2 channels acting on the closed and closed inactivated states.
    Pacheco-Rojas DO; Delgado-Ramírez M; Villatoro-Gómez K; Moreno-Galindo EG; Rodríguez-Menchaca AA; Sánchez-Chapula JA; Ferrer T
    Eur J Pharmacol; 2021 May; 899():174026. PubMed ID: 33722592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fluoxetine on cloned Kv4.3 potassium channels.
    Jeong I; Choi JS; Hahn SJ
    Brain Res; 2013 Mar; 1500():10-8. PubMed ID: 23348380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin-independent inhibition of KV1.3 by FK-506 (tacrolimus): a novel pharmacological property.
    Ahn HS; Kim SE; Choi BH; Choi JS; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Kwon OJ; Hahn SJ
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1714-22. PubMed ID: 17166943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.
    Caballero R; Gómez R; Núñez L; Moreno I; Tamargo J; Delpón E
    Cardiovasc Res; 2004 Dec; 64(3):457-66. PubMed ID: 15537499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of MiRP1 and DPP6 beta-subunits on the blockade induced by flecainide of Kv4.3/KChIP2 channels.
    Radicke S; Vaquero M; Caballero R; Gómez R; Núñez L; Tamargo J; Ravens U; Wettwer E; Delpón E
    Br J Pharmacol; 2008 Jun; 154(4):774-86. PubMed ID: 18536731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cardiac Kv1.5 and Kv4.3 potassium channels by the class Ia anti-arrhythmic ajmaline: mode of action.
    Fischer F; Vonderlin N; Zitron E; Seyler C; Scherer D; Becker R; Katus HA; Scholz EP
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Nov; 386(11):991-9. PubMed ID: 23832378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-à-gogo K(+) channel.
    Potet F; Bouyssou T; Escande D; Baró I
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1007-12. PubMed ID: 11714889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.